north american coral snake antivenin (equine)

Generic: coral snake (micrurus fulvius) immune globulin antivenin (equine)

Labeler: wyeth pharmaceuticals llc, a subsidiary of pfizer inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name north american coral snake antivenin (equine)
Generic Name coral snake (micrurus fulvius) immune globulin antivenin (equine)
Labeler wyeth pharmaceuticals llc, a subsidiary of pfizer inc.
Dosage Form INJECTION, POWDER, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

coral snake (micrurus fulvius) immune globulin antivenin (equine) 250 [arb'U]/10mL

Manufacturer
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Identifiers & Regulatory

Product NDC 0008-0423
Product ID 0008-0423_7a16fb9b-c963-48d9-90f9-b428857ab5de
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA101099
Listing Expiration 2026-12-31
Marketing Start 2016-10-12

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00080423
Hyphenated Format 0008-0423

Supplemental Identifiers

RxCUI
1858981
UNII
Y605XBM2GL

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name north american coral snake antivenin (equine) (source: ndc)
Generic Name coral snake (micrurus fulvius) immune globulin antivenin (equine) (source: ndc)
Application Number BLA101099 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 250 [arb'U]/10mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0008-0423-03) / 10 mL in 1 VIAL (0008-0423-01)
source: ndc

Packages (1)

0008-0423-03 1 VIAL in 1 CARTON (0008-0423-03) / 10 mL in 1 VIAL (0008-0423-01)

Ingredients (1)

coral snake (micrurus fulvius) immune globulin antivenin (equine) (250 [arb'U]/10mL)

Linked Drug Pages (1)

North American Coral Snake Antivenin (Equine) ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "7a16fb9b-c963-48d9-90f9-b428857ab5de", "openfda": {"unii": ["Y605XBM2GL"], "rxcui": ["1858981"], "spl_set_id": ["6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0008-0423-03)  / 10 mL in 1 VIAL (0008-0423-01)", "package_ndc": "0008-0423-03", "marketing_start_date": "20161012"}], "brand_name": "North American Coral Snake Antivenin (Equine)", "product_id": "0008-0423_7a16fb9b-c963-48d9-90f9-b428857ab5de", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "product_ndc": "0008-0423", "generic_name": "Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine)", "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "North American Coral Snake Antivenin (Equine)", "active_ingredients": [{"name": "CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE)", "strength": "250 [arb'U]/10mL"}], "application_number": "BLA101099", "marketing_category": "BLA", "marketing_start_date": "20161012", "listing_expiration_date": "20261231"}